Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia

Sabine Cerny-Reiterer, Anja Rabenhorst, Gabriele Stefanzl, Susanne Herndlhofer, Gregor Hoermann, Leonhard Müllauer, Sigrid Baumgartner, Christine Beham-Schmid, Wolfgang R. Sperr, Christine Mannhalter, Heinz Sill, Werner Linkesch, Michel Arock, Karin Hartmann, Peter Valent*

*Corresponding author for this work
13 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia'. Together they form a unique fingerprint.

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science